Loan & DebtJun 15, 2026, 04:12 PM
Ironwood Pharmaceuticals Repays $200M Convertible Senior Notes
AI Summary
Ironwood Pharmaceuticals, Inc. announced the full repayment of $200.0 million in aggregate principal amount of its 1.50% convertible senior notes due 2026. The repayment was made on schedule using the company's available cash on hand. No conversions were exercised by noteholders, and the associated capped call transactions terminated upon expiry.
Key Highlights
- Ironwood Pharmaceuticals repaid $200.0 million aggregate principal amount of its 1.50% convertible senior notes.
- The notes were due in 2026 and were repaid at their scheduled maturity on June 15, 2026.
- Repayment was funded using proceeds from available cash on hand.
- No conversions were exercised by holders of the 2026 Convertible Notes.
- Capped call transactions related to the notes terminated upon expiry.
Price Impact
More from IRWD